Real-world effectiveness of ceftazidime/avibactam versus polymyxin B in treating patients with carbapenem-resistant Gram-negative bacterial infections

医学 头孢他啶/阿维巴坦 内科学 多粘菌素 多粘菌素B 碳青霉烯 肺炎克雷伯菌 抗生素 头孢他啶 哌拉西林/他唑巴坦 共病 死亡率 重症监护医学 哌拉西林 微生物学 铜绿假单胞菌 生物 细菌 大肠杆菌 遗传学 基因 生物化学
作者
Junyan Qu,Xu Jian,Yanbin Liu,Chenggong Hu,Cejun Zhong,Xiaoju Lv
出处
期刊:International Journal of Antimicrobial Agents [Elsevier BV]
卷期号:62 (2): 106872-106872 被引量:11
标识
DOI:10.1016/j.ijantimicag.2023.106872
摘要

To compare the effectiveness of ceftazidime/avibactam (CAZ/AVI) and polymyxin B against carbapenem-resistant Gram-negative bacteria (CRGNB) infections in western China.The medical records of patients with CRGNB infections in this hospital from 2018-2022 were retrospectively reviewed. The data included demographic characteristics, laboratory results, antibiotic strategies and clinical outcomes.A total of 378 patients with CRGNB infections were enrolled, including 112 patients in the CAZ/AVI group and 266 patients in the polymyxin B group. The most common pathogen was carbapenem-resistant Klebsiella pneumoniae (44.44%). The rates of treatment failure at 28 days (65.04% vs. 45.54%; P = 0.000) and 28-day in-hospital mortality (20.30% vs. 9.82%; P = 0.014) in the polymyxin B group were higher than those in the CAZ/AVI group. Multivariable analysis revealed that multiple organ dysfunction syndrome (OR 2.730; P = 0.017), acute renal failure (OR 2.595; P = 0.020), higher Charlson comorbidity index (CCI) (OR 1.184; P = 0.011) and Acute Physiology And Chronic Health Evaluation (APACHE) Ⅱ scores (OR 1.149; P = 0.000) were independent risk factors for treatment failure, whereas CAZ/AVI therapy (OR 0.333; P = 0.002) had a protective effect. Multivariate Cox regression analysis revealed that CCI ≥ 5 and APACHE II score ≥ 15 were associated with a higher 28-day in-hospital mortality rate (P < 0.001).CAZ/AVI therapy was associated with treatment success among patients with CRGNB infection. However, CAZ/AVI therapy did not improve 28-day in-hospital survival compared with polymyxin B. The CCI ≥ 5 and APACHE II score ≥ 15 affected 28-day in-hospital mortality of CRGNB-infected patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hikh发布了新的文献求助10
1秒前
木丁发布了新的文献求助10
2秒前
务实奎完成签到,获得积分10
2秒前
小小猪发布了新的文献求助10
3秒前
Jian发布了新的文献求助10
3秒前
Emma应助小阿超采纳,获得10
4秒前
嘤滢莹发布了新的文献求助10
5秒前
研友_VZG7GZ应助细腻曼冬采纳,获得10
5秒前
上官若男应助黄鱼面采纳,获得10
5秒前
深情的白薇完成签到,获得积分10
5秒前
Kenny发布了新的文献求助10
5秒前
6秒前
6秒前
6秒前
香蕉觅云应助不想吃大蒜采纳,获得10
6秒前
烟花应助AI_S采纳,获得10
6秒前
壮观听芹完成签到,获得积分20
7秒前
7秒前
abcd完成签到,获得积分10
8秒前
shiyi应助去晒月亮采纳,获得10
8秒前
hsm完成签到,获得积分10
9秒前
10秒前
酷酷的小鹿关注了科研通微信公众号
11秒前
12秒前
zcvxd发布了新的文献求助20
12秒前
Mars_1108发布了新的文献求助10
12秒前
李健的小迷弟应助万晓博采纳,获得30
12秒前
13秒前
cqsjy完成签到,获得积分10
13秒前
paradox完成签到 ,获得积分10
14秒前
14秒前
15秒前
KCC发布了新的文献求助10
15秒前
15秒前
15秒前
迷路旭发布了新的文献求助10
16秒前
16秒前
小二郎应助小巧念波采纳,获得10
17秒前
香蕉觅云应助图图烤肉采纳,获得10
17秒前
元g发布了新的文献求助10
17秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974943
求助须知:如何正确求助?哪些是违规求助? 3519467
关于积分的说明 11198482
捐赠科研通 3255728
什么是DOI,文献DOI怎么找? 1797904
邀请新用户注册赠送积分活动 877261
科研通“疑难数据库(出版商)”最低求助积分说明 806224